Literature DB >> 25113328

[Prurigo nodularis: its association with dermatoses and systemic disorders].

T Mettang1, A Vonend, U Raap.   

Abstract

BACKGROUND: Prurigo is seen in various dermatological diseases, but also in systemic and neurological diseases.
OBJECTIVES: Which diseases in dermatology, internal medicine and neurology are linked to prurigo nodularis?
MATERIAL AND METHODS: We describe the various entities that are associated with prurigo and discuss pathogenetic and therapeutic implications.
RESULTS: In dermatology prurigo nodularis is most frequently seen in atopic dermatitis, but also in cutaneous lymphomas, mycobacterial skin infections and bullous diseases. Among systemic diseases, prurigo nodularis frequently is associated with pruritus of chronic renal or hepatic diseases. Prurigo nodularis is also seen in hematological and metabolic diseases (such as solid tumors, lymphoma, diabetes mellitus). The pathophysiology of prurigo is only partly understood. Treatment of prurigo nodularis is often challenging and a multimodal approach is advisable.
CONCLUSION: Prurigo nodularis is a skin manifestation of chronic pruritus caused by various diseases in dermatology, internal medicine and neurology. An interdisciplinary approach should be taken for diagnosis and therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25113328     DOI: 10.1007/s00105-014-2755-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   1.198


  43 in total

1.  Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients.

Authors:  Nils Weigelt; Dieter Metze; Sonja Ständer
Journal:  J Cutan Pathol       Date:  2009-11-30       Impact factor: 1.587

2.  Uraemic pruritus: relief of itching by gabapentin and pregabalin.

Authors:  Hugh Rayner; Jyoti Baharani; Steve Smith; Vijayan Suresh; Indranil Dasgupta
Journal:  Nephron Clin Pract       Date:  2013-03-28

3.  Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori.

Authors:  Rei Akashi; Naoko Ishiguro; Satoru Shimizu; Makoto Kawashima
Journal:  J Dermatol       Date:  2010-11-22       Impact factor: 4.005

4.  Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.

Authors:  Florence Magand; Mathieu Nacher; Céline Cazorla; Frederic Cambazard; Dominique Sainte Marie; Pierre Couppié
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-05-28       Impact factor: 2.184

5.  Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison with lactose maldigestion/malabsorption.

Authors:  D Mishkin; L Sablauskas; M Yalovsky; S Mishkin
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

6.  Randomised crossover trial of naltrexone in uraemic pruritus.

Authors:  G Peer; S Kivity; O Agami; E Fireman; D Silverberg; M Blum; A laina
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

7.  Clinical features of pruritus among patients undergoing maintenance hemodialysis.

Authors:  B A Gilchrest; R S Stern; T I Steinman; R S Brown; K A Arndt; W W Anderson
Journal:  Arch Dermatol       Date:  1982-03

8.  A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy.

Authors:  Dirk R Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
Journal:  Nephrol Dial Transplant       Date:  2004-05-18       Impact factor: 5.992

9.  [Pruritus sine materia: a prospective study of 95 patients].

Authors:  Y Afifi; F Aubin; E Puzenat; A Degouy; D Aubrion; B Hassam; P Humbert
Journal:  Rev Med Interne       Date:  2004-07       Impact factor: 0.728

10.  Identifying effective treatments for uremic pruritus.

Authors:  J K Tan; H F Haberman; A J Coldman
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

View more
  4 in total

1.  [Chronic prurigo].

Authors:  M P Pereira; T Nau; C Zeidler; S Ständer
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

2.  [Treatment of chronic itch in systemic disease. Current standards].

Authors:  T Mettang; S Ständer; A E Kremer
Journal:  Internist (Berl)       Date:  2015-12       Impact factor: 0.743

3.  Chronic Prurigo: An Unusual Presentation of Hodgkin Lymphoma.

Authors:  Shireen Dumont; Marc Péchère; Laurence Toutous Trellu
Journal:  Case Rep Dermatol       Date:  2018-05-17

4.  Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.

Authors:  Sonja Ständer; Miriam Ketz; Nils Kossack; Divine Akumo; Marc Pignot; Sylvie Gabriel; Rajeev Chavda
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.